agilon health, inc. (NYSE:AGL) Stake Boosted by Creative Planning

Creative Planning increased its position in shares of agilon health, inc. (NYSE:AGL) by 118.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 66,824 shares of the company’s stock after acquiring an additional 36,241 shares during the period. Creative Planning’s holdings in agilon health were worth $437,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of the company. J.Safra Asset Management Corp lifted its holdings in shares of agilon health by 626.1% during the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after buying an additional 3,625 shares during the last quarter. CWM LLC raised its holdings in shares of agilon health by 406.5% during the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after purchasing an additional 7,288 shares in the last quarter. Nisa Investment Advisors LLC acquired a new stake in shares of agilon health in the 2nd quarter valued at $60,000. Bleakley Financial Group LLC bought a new stake in agilon health in the first quarter worth $65,000. Finally, Allspring Global Investments Holdings LLC raised its holdings in agilon health by 17,790.0% during the second quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock valued at $70,000 after buying an additional 10,674 shares in the last quarter.

Insider Buying and Selling at agilon health

In other news, CEO Steven Sell acquired 20,000 shares of the business’s stock in a transaction dated Thursday, September 12th. The stock was purchased at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the acquisition, the chief executive officer now owns 67,590 shares of the company’s stock, valued at $227,102.40. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 3.20% of the company’s stock.

Analyst Ratings Changes

AGL has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Evercore ISI reduced their price target on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a report on Tuesday, October 8th. Bank of America cut agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target for the company. in a report on Wednesday, October 2nd. Benchmark restated a “buy” rating and set a $9.00 price objective on shares of agilon health in a research report on Thursday, August 8th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $8.00 target price on shares of agilon health in a research report on Wednesday, August 7th. Two research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $8.03.

agilon health Stock Performance

Shares of AGL opened at $3.32 on Wednesday. The stock has a 50 day moving average of $4.01 and a 200 day moving average of $5.27. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.04. agilon health, inc. has a 12 month low of $2.99 and a 12 month high of $20.37. The company has a market capitalization of $1.37 billion, a price-to-earnings ratio of -4.74 and a beta of 0.54.

agilon health (NYSE:AGL) last released its earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.07). The business had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.56 billion. agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The business’s revenue for the quarter was up 38.7% on a year-over-year basis. During the same period last year, the business posted ($0.04) earnings per share. As a group, sell-side analysts forecast that agilon health, inc. will post -0.32 earnings per share for the current year.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.